精品文档---下载后可任意编辑Ⅲ 期非小细胞肺癌放化综合治疗的疗效分析的开题报告【摘要】随着科技的进展和医学水平的提高，非小细胞肺癌（NSCLC）的治疗方式也从单一的手术治疗逐渐进展到综合治疗。本讨论旨在评估Ⅲ期 NSCLC 放化综合治疗的疗效，并探讨其对预后的影响。通过回顾性分析 2024 年至 2024 年在医院接受放化综合治疗的Ⅲ期 NSCLC 患者的临床资料，统计生存率、复发率、药物毒副作用等指标并进行统计学分析。讨论结果表明，Ⅲ期 NSCLC 放化综合治疗具有较高的局部控制率和全身治疗效果，但同时也伴随着一定的毒副作用。对于Ⅲ期 NSCLC 患者而言，放化综合治疗不仅可以提高治疗效果，同时也是一种可行的治疗选择。【关键词】非小细胞肺癌；放化综合治疗；临床讨论；疗效评估；药物毒副作用【Abstract】With the development of technology and the improvement of medical level, the treatment of non-small cell lung cancer (NSCLC) has gradually developed from single surgical treatment to comprehensive treatment. The purpose of this study was to evaluate the efficacy of radiotherapy and chemotherapy in the comprehensive treatment of stage III NSCLC and explore its impact on prognosis. The clinical data of patients with stage III NSCLC who received radiotherapy and chemotherapy in the hospital from 2024 to 2024 were retrospectively analyzed, and survival rate, recurrence rate, drug toxic and side effects were statistically analyzed. The results showed that comprehensive treatment of stage III NSCLC had a relatively high rate of local control and overall treatment effect, but it was also associated with certain toxic and side effects. For patients with stage III NSCLC, radiotherapy and chemotherapy can not only improve treatment effect, but also a feasible treatment option.【Key words】non-small cell lung cancer; radiotherapy and chemotherapy; clinical study; efficacy evaluation; drug toxic and side effects
